Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF.
Sin MK, Allman RM, Faselis C, Aronow WS, Brown CJ, Lam PH, Wu WC, Zeng-Treitler Q, Patel SS, Raman VK, Zhang S, Sheriff HM, Morgan CJ, Heidenreich PA, Fonarow GC, Ahmed A.
Sin MK, et al. Among authors: brown cj.
Am J Med. 2024 Nov 12:S0002-9343(24)00710-1. doi: 10.1016/j.amjmed.2024.10.019. Online ahead of print.
Am J Med. 2024.
PMID: 39551174